Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression
Data up to Jan 2025
Total Citations Per Year
Abstract
References (25)
Progression From Compensated Hypertrophy to Failure in the Pressure-Overloaded Human Heart
2003 • 1,023 citations
Matrix Metalloproteinase Inhibition After Myocardial Infarction
2001 • 596 citations
The Soluble Catalytic Domain of Membrane Type 1 Matrix Metalloproteinase Cleaves the Propeptide of Progelatinase A and Initiates Autoproteolytic Activation
1996 • 564 citations
Molecular Cloning and Characterization of Human Tissue Inhibitor of Metalloproteinase 4
1996 • 547 citations
Gene Expression in Fibroblasts and Fibrosis
2002 • 508 citations
A Matrix Metalloproteinase Induction/Activation System Exists in the Human Left Ventricular Myocardium and Is Upregulated in Heart Failure
2000 • 470 citations
Differential Expression of Tissue Inhibitors of Metalloproteinases in the Failing Human Heart
1998 • 376 citations
Time-Dependent Changes in Matrix Metalloproteinase Activity and Expression During the Progression of Congestive Heart Failure
1998 • 372 citations
Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat
2000 • 293 citations
Fibrosis of the left atria during progression of heart failure is associated with increased matrix metalloproteinases in the rat
2003 • 190 citations
Excessive activation of matrix metalloproteinases coincides with left ventricular remodeling during transition from hypertrophy to heart failure in hypertensive rats
2002 • 142 citations
Cardiac remodelling in end stage heart failure: upregulation of matrix metalloproteinase (MMP) irrespective of the underlying disease, and evidence for a direct inhibitory effect of ACE inhibitors on MMP
2002 • 138 citations
MMP/TIMP expression in spontaneously hypertensive heart failure rats: the effect of ACE- and MMP-inhibition
2000 • 136 citations
Differential effects of pressure or volume overload on myocardial MMP levels and inhibitory control
2000 • 128 citations
Temporal regulation of extracellular matrix components in transition from compensatory hypertrophy to decompensatory heart failure
1999 • 122 citations
Cell cycle-associated accumulation of tissue inhibitor of metalloproteinases-1 (TIMP-1) in the nuclei of human gingival fibroblasts
1998 • 98 citations
MMP inhibition modulates TNF-α transgenic mouse phenotype early in the development of heart failure
2002 • 74 citations
Expression of Matrix Metalloproteinases in Patients With Acute Myocardial Infarction
2001 • 70 citations
Activation of gelatinase–tissue-inhibitors-of-metalloproteinase complexes by matrilysin
1998 • 68 citations
Regression of Left Ventricular Hypertrophy After Surgical Therapy for Aortic Stenosis Is Associated With Changes in Extracellular Matrix Gene Expression
2001 • 53 citations
Changes in collagen metabolism in response to endothelin-1: Evidence for fibroblast heterogeneity
1996 • 46 citations
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in hamster aortic atherosclerosis: correlation with in-situ zymography
2002 • 33 citations
Fibroblast subpopulations in intra‐oral wound healing
2003 • 23 citations
Defects in Matrix Metalloproteinase Inhibitory Stoichiometry and Selective MMP Induction in Patients with Nonischemic or Ischemic Dilated Cardiomyopathy
1999 • 19 citations
Remodeling der extrazellulären Matrix bei dilatativer Kardiomyopathie
2002 • 18 citations